Showing results (101-110 of 108) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosisC Cremolini, M Di Bartolomeo, A Amatu, et al.British Journal of Cancer|July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancerF Loupakis, A Ruzzo, C Cremolini, et al.British Journal of Cancer|October 29, 2014
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsA D'Incecco, M Andreozzi, V Ludovini, et al.British Journal of Cancer|May 6, 2015
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resectionM Schirripa, F Bergamo, C Cremolini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONOC Cremolini, C Antoniotti, S Lonardi, et al.ESMO Open|December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunitiesM Simbolo, G Centonze, G Ali, et al.ESMO Open|March 6, 2021
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 studyB Borelli, E Fontana, M Giordano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control studyC Cremolini, F Morano, R Moretto, et al.Pageof 11